Literature DB >> 10675700

High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.

L Maggi1, R Bruni, U Conte.   

Abstract

High molecular weight polyethylene oxides (PEOs) have recently been proposed as an alternative to hydroxypropylmethylcellulose (HPMC) in controlled release matrix tablets. In this study, we compared the performance of PEO and HPMC polymers when employed in the Geomatrix technology, a versatile, well-known method to achieve extended release of drugs at a constant rate. Four core formulations were prepared, containing a soluble drug (diltiazem) and, alternatively, PEO or HPMC of two different viscosity grades. These formulations have the same composition except for the polymer employed. Similarly, four barrier formulations were also prepared, which only differ in the kind of polymer employed. Three-layer Geomatrix systems were then prepared using these core and barrier formulations. The release profiles of the different three-layer systems obtained were compared, to verify if PEO could efficiently replace HPMC in this type of dosage form. The results show that slower release rates can be obtained from the plain matrices containing HPMC compared to PEO, moreover HPMC, used in the barrier formulations, is generally more efficient in controlling drug release rate in three-layer Geomatrix systems.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675700     DOI: 10.1016/s0378-5173(99)00402-0

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

1.  Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gum.

Authors:  Mukesh C Gohel; Shital H Bariya
Journal:  AAPS PharmSciTech       Date:  2009-05-15       Impact factor: 3.246

2.  Formulation variables influencing drug release from layered matrix system comprising chitosan and xanthan gum.

Authors:  Thawatchai Phaechamud; Garnpimol C Ritthidej
Journal:  AAPS PharmSciTech       Date:  2008-07-25       Impact factor: 3.246

3.  The Properties of HPMC:PEO Extended Release Hydrophilic Matrices and their Response to Ionic Environments.

Authors:  Anran Hu; Chen Chen; Michael D Mantle; Bettina Wolf; Lynn F Gladden; Ali Rajabi-Siahboomi; Shahrzad Missaghi; Laura Mason; Colin D Melia
Journal:  Pharm Res       Date:  2016-09-15       Impact factor: 4.200

4.  Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.

Authors:  Emad B Basalious; Wessam El-Sebaie; Omaima El-Gazayerly
Journal:  AAPS PharmSciTech       Date:  2011-06-24       Impact factor: 3.246

5.  Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs.

Authors:  C D Bertol; P R Oliveira; G Kuminek; G S Rauber; H K Stulzer; M A S Silva
Journal:  Ann Trop Med Parasitol       Date:  2011-10

6.  A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.

Authors:  Roger Messin; Tamas Fenyvesi; Fabienne Carreer-Bruhwyler; Jacques Crommen; Patrice Chiap; Philippe Hubert; Claude Dubois; Jean-Pierre Famaey; Joseph Géczy
Journal:  Eur J Clin Pharmacol       Date:  2003-05-07       Impact factor: 2.953

7.  Variables influencing drug release from layered matrix system comprising hydroxypropyl methylcellulose.

Authors:  Thawatchai Phaechamud
Journal:  AAPS PharmSciTech       Date:  2008-05-24       Impact factor: 3.246

8.  Use of fine particle ethylcellulose as the diluent in the production of pellets by extrusion-spheronization.

Authors:  Rama Mallipeddi; Kalyan K Saripella; Steven H Neau
Journal:  Saudi Pharm J       Date:  2013-11-16       Impact factor: 4.330

9.  Probing the Release of Bupropion and Naltrexone Hydrochloride Salts from Biopolymeric Matrices of Diverse Chemical Structures.

Authors:  Angeliki Siamidi; Aikaterini Dedeloudi; Marilena Vlachou
Journal:  Polymers (Basel)       Date:  2021-04-30       Impact factor: 4.329

10.  Formulation development and stability studies of norfloxacin extended-release matrix tablets.

Authors:  Paulo Renato Oliveira; Cassiana Mendes; Lilian Klein; Maximiliano da Silva Sangoi; Larissa Sakis Bernardi; Marcos Antônio Segatto Silva
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.